title: Pharmacological characterization of a new Ca(2+) sensitizer.
abstract: The benzimidazole molecule was modified to synthesize a Ca(2+) sensitizer devoid of additional effects associated with Ca(2+) overload. Newly synthesized compounds, termed 1, 2, 3, 4, and 5, were evaluated in spontaneously beating and electrically driven atria from reserpine-treated guinea pigs. Compound 3 resulted as the most effective positive inotropic agent, and experiments were performed to study its mechanism of action. In spontaneously beating atria, the inotropic effect of 3 was concentration-dependent (3.0 microM-0.3 mM). Compound 3 was more potent and more active than the structurally related Ca(2+) sensitizers sulmazole and caffeine, but unlike them it did not increase the heart rate. In electrically driven atria, the inotropic activity of 3 was well preserved and it was not inhibited by propranolol, prazosin, ranitidine, pyrilamine, carbachol, adenosine deaminase, or ruthenium red. At high concentrations (0.1-1.0 mM) 3 inhibited phosphodiesterase-III, whereas it did not affect Na(+)/K(+)-ATPase, sarcolemmal Ca(2+)-ATPase, Na(+)/Ca(2+) exchange carrier, or sarcoplasmic reticulum Ca(2+) pump activities of guinea pig heart. In skinned fibers obtained from guinea pig papillary muscle and skeletal soleus muscle, compound 3 (0.1 mM, 1 mM) shifted the pCa/tension relation curve to the left, with no effect on maximal tension and no signs of toxicity. Compound 3 did not influence the basal or raised tone of guinea pig isolated aorta rings, whose cells do not contain the contractile protein troponin. The present results indicate that the inotropic effect of compound 3 seems to be primarily sustained by sensitization of the contractile proteins to Ca(2+).
authors.affiliation: Department of Pharmacology and Anesthesiology, University of Padova, Padova, Italy. dorigo@ux1.unipd.it
authors.forename: P
authors.initials: P
authors.lastname: Dorigo
authors.forename: M
authors.initials: M
authors.lastname: Floreani
authors.forename: G
authors.initials: G
authors.lastname: Santostasi
authors.forename: I
authors.initials: I
authors.lastname: Maragno
authors.forename: D
authors.initials: D
authors.lastname: Danieli-Betto
authors.forename: E
authors.initials: E
authors.lastname: Germinario
authors.forename: S M
authors.initials: SM
authors.lastname: Magno
authors.forename: G
authors.initials: G
authors.lastname: Primofiore
authors.forename: A M
authors.initials: AM
authors.lastname: Marini
authors.forename: F
authors.initials: F
authors.lastname: Da Settimo
mesh_terms: D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects
chemical_list: D001562:Benzimidazoles; D007093:Imidazoles; D002110:Caffeine; C029758:sulmazole; D002118:Calcium